title: Subcutaneous erythropoietin alpha (Eprex) is more painful than erythropoietin beta (Recormon)
authors.forename: M N
authors.initials: MN
authors.lastname: Cumming
authors.forename: I M
authors.initials: IM
authors.lastname: Sharkey
authors.forename: J
authors.initials: J
authors.lastname: Sharp
authors.forename: N D
authors.initials: ND
authors.lastname: Plant
authors.forename: M G
authors.initials: MG
authors.lastname: Coulthard
mesh_terms: D000328:Adult; D000779:Anesthetics, Local / Q000627:therapeutic use; D002648:Child; D004339:Drug Compounding; D004921:Erythropoietin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008012:Lidocaine / Q000627:therapeutic use; D000077442:Lidocaine, Prilocaine Drug Combination; D008297:Male; D010146:Pain / Q000139:chemically induced*; D011318:Prilocaine / Q000627:therapeutic use; D011994:Recombinant Proteins; D051437:Renal Insufficiency / Q000188:drug therapy
chemical_list: D000779:Anesthetics, Local; D000077442:Lidocaine, Prilocaine Drug Combination; D011994:Recombinant Proteins; D011318:Prilocaine; D004921:Erythropoietin; D008012:Lidocaine